🔗 Share this article Social Media Influencers Driving Unofficial Trade for Unapproved Slimming Drug A shadow market for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on communication apps, according to recent findings. Experimental Drug Gaining Traction Via Social Media The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers. Active Commerce on Messaging Platforms Separately, a robust market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Vendors market the substance there before directing buyers to WhatsApp for purchases. Understanding Retatrutide This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic. Medical Professionals Voice Worries Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to users administering substances of unknown origin. Several professionals stated the demand for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro. Regulatory Status and Implementation Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the British medical regulations. Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and customer regulations, risking penalties, legal action or imprisonment. Service Reaction and Material Elimination Based on TikTok, the platform has removed problematic content and banned related keywords and search suggestions. The company stated it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies. Digital Marketplace Operations Research also discovered groups with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, glowing testimonials and detailed instructions for mixing or injecting at home. After minutes of joining one group, a seller shared WhatsApp details, where most purchases occur. The vendor provided an guidebook and promised delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about weight, health issues or previous experience. Item Information and Pricing Inside these groups, posts display dark colored parcels with Royal Mail labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.” Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give contradictory answers varying between a several days to “depends on your body”. Platform Moderation and Security Actions A spokesperson for Telegram said it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”. Medical Professional Warnings “People are administering materials they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U. Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained. Her team has previously seen patients injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.” Producer Position A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may subject users to potentially significant health risks”.